S W Han1, E McColl, N Steen, J R Barton, M R Welfare. 1. University of Newcastle Regional School of Medicine, North Tyneside General Hospital, North Shields, Tyne and Wear, UK.
Abstract
BACKGROUND: The validity and reliability of the Inflammatory Bowel Disease Questionnaire (IBDQ) needed to be confirmed before its use in the UK. METHODS: The IBDQ was administered to 28 subjects with ulcerative colitis (UC) on 3 separate occasions over a period of 4 weeks, twice by an interviewer and once by self-completion. Convergent and concurrent validity was assessed by using the Colitis Activity Index (CAI) and the Short Form 36 Health Survey (SF-36). Test-retest reliability and internal consistency were also tested. RESULTS: There were moderately high Pearson correlations between related IBDQ domains and SF-36 dimensions and also between the CAI score and the IBDQ Bowel domain and the SF-36 Pain dimension. Cronbach's alpha, corrected item-total correlations, and intra-class correlation coefficients were high. CONCLUSIONS: The IBDQ is a valid and reliable health-related quality of life scale for use in patients with UC and is suitable for use in the UK.
BACKGROUND: The validity and reliability of the Inflammatory Bowel Disease Questionnaire (IBDQ) needed to be confirmed before its use in the UK. METHODS: The IBDQ was administered to 28 subjects with ulcerative colitis (UC) on 3 separate occasions over a period of 4 weeks, twice by an interviewer and once by self-completion. Convergent and concurrent validity was assessed by using the Colitis Activity Index (CAI) and the Short Form 36 Health Survey (SF-36). Test-retest reliability and internal consistency were also tested. RESULTS: There were moderately high Pearson correlations between related IBDQ domains and SF-36 dimensions and also between the CAI score and the IBDQ Bowel domain and the SF-36 Pain dimension. Cronbach's alpha, corrected item-total correlations, and intra-class correlation coefficients were high. CONCLUSIONS: The IBDQ is a valid and reliable health-related quality of life scale for use in patients with UC and is suitable for use in the UK.
Authors: Aaron Yarlas; Martha Bayliss; Joseph C Cappelleri; Stephen Maher; Andrew G Bushmakin; Lea Ann Chen; Alireza Manuchehri; Paul Healey Journal: Qual Life Res Date: 2017-08-28 Impact factor: 4.147
Authors: Lisa M Lix; Tolulope T Sajobi; Richard Sawatzky; Juxin Liu; Nancy E Mayo; Yuhui Huang; Lesley A Graff; John R Walker; Jason Ediger; Ian Clara; Kathryn Sexton; Rachel Carr; Charles N Bernstein Journal: Qual Life Res Date: 2012-06-15 Impact factor: 4.147
Authors: K-H Janke; A Raible; M Bauer; P Clemens; C Meisner; W Häuser; U Steder-Neukamm; G Henrich; P Herschbach; M Gregor; B Klump Journal: Int J Colorectal Dis Date: 2003-10-28 Impact factor: 2.571
Authors: Zoe Tolkien; Dora I A Pereira; Laura Prassmayer; Emily Fitt; Gerda Pot; Simon M Greenfield; Jonathan J Powell Journal: Nutr J Date: 2013-11-23 Impact factor: 3.271